Drug comparisons
Dihydroergotamine vs Ubrogepant
Compare Dihydroergotamine vs Ubrogepant for migraines. DHE has black-box for vascular risks; Ubrelvy is safer CGRP oral option.
No comparison dimensions are available for this page.
Clinical context
Patients exploring acute migraine options when switching from older ergots like DHE to newer gepants amid cardiovascular concerns.
Bottom line
Ubrogepant generally provides a safer profile for most, though dihydroergotamine remains viable for select refractory cases.
All medication comparisons